Novartis Reaches New 12-Month High at $77.10 (NVS)
Novartis (NYSE:NVS)’s share price reached a new 52-week high during trading on Friday, American Banking News reports. The stock traded as high as $77.10 and last traded at $77.08, with a volume of 1,779,046 shares traded. The stock had previously closed at $76.68.
Separately, analysts at Barclays Capital downgraded shares of Novartis (NYSE:NVS) from an “equal weight” rating to an “underweight” rating in a research note to investors on Monday, September 16th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. Novartis presently has a consensus rating of “Hold” and an average price target of $81.00.
Novartis has a 52-week low of $58.60 and a 52-week high of $77.10. The stock has a 50-day moving average of $74.8 and a 200-day moving average of $72.85. The company has a market cap of $188.6 billion and a price-to-earnings ratio of 19.86.
Novartis (NYSE:NVS) last posted its quarterly earnings results on Wednesday, July 17th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.01. The company had revenue of $14.50 billion for the quarter, compared to the consensus estimate of $14.39 billion. During the same quarter in the previous year, the company posted $1.38 earnings per share. The company’s revenue for the quarter was up 1.3% on a year-over-year basis.
Novartis AG is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.